Clinical Trial Update: SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 study comparing SIR-Spheres Y-90 resin microspheres with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SIR-Spheres Microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: Sirtex Medical | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED